Main Street Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.02K Hold
62
﹤0.01% 626
2025
Q1
$2.11K Hold
62
﹤0.01% 666
2024
Q4
$2.44K Sell
62
-488
-89% -$19.2K ﹤0.01% 643
2024
Q3
$25.8K Hold
550
0.01% 355
2024
Q2
$29.7K Hold
550
0.01% 340
2024
Q1
$37.5K Hold
550
0.02% 323
2023
Q4
$34.4K Buy
+550
New +$34.4K 0.01% 485